Executive Stock Sales Continue Amid Enfusion's Acquisition Talks High-ranking executives at Enfusion, including the COO and CFO, have sold shares worth a combined $183,220 to cover tax obligations. These sales come as the company's stock trades near its 52-week high, reflecting investor interest amid acquisition developments with Clearwater Analytics. Both executives retain substantial holdings in the firm.34